Tego Science, Inc.
Tego Science makes cell therapies Holoderm and Rosmir, and sells the 3D skin model Neoderm for CDMO and animal-alternative testing.
Price
Change
Market cap
Business overview
Source: DART corporate disclosureFounded in 2001 and listed on KOSDAQ in 2014, Tego Science is a biotech company that develops and manufactures cell therapies using cell culture technology. It sells the autologous cell therapies Holoderm, approved in 2002, and the wrinkle-improvement therapy Rosmir, and commercializes the 3D cultured skin product Neoderm for animal-alternative testing. It holds 3 of Korea's 16 approved cell therapy products (5 of 19 indications), runs domestic Phase 2b/3 and US Phase 2 trials for a rotator cuff tear therapy, and is expanding into CDMO services across the full development cycle.
Products & technology
- HolodermAutologous cell therapy
- RosmirAutologous cell therapy for wrinkle improvement
- Neoderm3D cultured skin used for animal-alternative testing and drug candidate efficacy prediction
Regulatory approvals
data.go.kr3 Korean MFDS drug approvals · 2021 / 1 Korean MFDS device approvals · 2025
- MFDSDressing, fluid-impermeable film2025-03-04Product approval · Class 2제인 25-4163 호
- MFDS drugHoloderm2021-08-27Drug · Prescription · Approval202106197
- MFDS drugKaloderm2021-08-27Drug · Prescription · Approval202106210
- MFDS drugRosmir2021-08-24Drug · Prescription · Approval202106147
Clinical trials
data.go.kr9 MFDS clinical trial authorisations · 2012–2024 (Phase 1 3 · Phase 2b/3 1 · Phase 1/2 1 · Phase 3 1 · Phase 1/3 1)
- Phase 1TPX-1152024-07-25
1 trial site
- Phase 2b/3TPX-1152023-05-08
2 trial sites
- Phase 1/2TPX-1152020-03-25
2 trial sites
- Phase 3TPX-1052018-11-15
4 trial sites
- Phase 1/3TPX-1142018-03-08
2 trial sites
- Phase 1TPX-1052015-09-17
2 trial sites
- Phase 2bTPX-1112013-11-14
2 trial sites
- Phase 1TPX-1022013-05-16
1 trial site
- Phase 2TPX-1032012-10-11
1 trial site
R&D and key agreements
Source: DART corporate disclosure주름개선용 동종유래 세포치료제 · 주름개선 · 국내 임상신청 준비 중 · Developed to improve commercial viability of the approved autologous therapy Rosmir
건질환(회전근개 파열 등) 치료용 자기유래·동종유래 세포치료제 · 회전근개 파열 등 건질환 · 국내 임상2b/3상 진행 중, 미국 임상2상(IND 승인) 진행 중 · Extension of R&D into musculoskeletal disease
Companies approved for the same productsBiotech & Drug Discovery
Ranked by how many MFDS product categories overlap. Not a ranking — a pointer to where to look.
Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.
Daehan Pharmaceutical, founded in 1963 and KOSDAQ-listed in 1994, manufactures intravenous fluid pharmaceuticals.
KOSDAQ-listed comprehensive healthcare and pharmaceutical company behind the gum treatment Insadol and the wound-care ointment Madecassol.
Dongwha Pharm, founded in 1897 and KOSPI-listed in 1976, is a diversified company centered on pharmaceuticals.
KOSDAQ-listed medical device company producing human tissue implants Bella Cell HD and SureFuse.
KOSDAQ-listed aesthetics and CMO company behind the Elravie/Revolax hyaluronic-acid fillers and Leedstox botulinum toxin.
Founded and listed on KOSPI in 2012 upon spin-off from the former Kolmar Korea, KOLMAR KOREA runs cosmetics ODM, prescription drugs, and packaging.
KOSDAQ-listed medical device company producing PDRN pharmaceuticals, HA fillers, and Rejuran-branded cosmetics.
Wonbiogen Co.,Ltd., established September 2018, listed on KOSDAQ in December 2018, manufactures wound dressings and moist wound dressings.
KOSDAQ-listed integrated security company behind the V3 antivirus and AhnLab TrusGuard and XDR solutions.
Organoid-based biotech founded 2018, KOSDAQ-listed 2025, developing the ATORM-C regenerative therapeutic and ODISEI evaluation solution.
Genomics and drug developer behind the osteoarthritis drug Acelex and the AI-driven healthcare platform Invites Loop.
Sources and updates
- Company basics
- Korea Exchange · DART
- Business content
- Compiled from disclosure filings
- AI visibility
- Measured 2026-08-13
This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.
Request a correction or addition